<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=MBIP</id>
	<title>MBIP - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=MBIP"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=MBIP&amp;action=history"/>
	<updated>2026-04-08T13:51:56Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=MBIP&amp;diff=5141&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein) [BM-015]  ==Publications==  {{medline-entr...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=MBIP&amp;diff=5141&amp;oldid=prev"/>
		<updated>2021-05-12T13:30:59Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein) [BM-015]  ==Publications==  {{medline-entr...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein) [BM-015]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Long-term caloric restriction ameliorates the decline in diastolic function in humans.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/16412867&lt;br /&gt;
|abstract=We determined whether caloric restriction (CR) has cardiac-specific effects that attenuate the established aging-associated impairments in diastolic function (DF). Caloric restriction retards the aging process in small mammals; however, no information is available on the effects of long-term CR on human aging. In healthy individuals, Doppler echocardiography has established the pattern of aging-associated DF impairment, whereas little change is observed in systolic function (SF). Diastolic function was assessed in 25 subjects (age 53  /- 12 years) practicing CR for 6.5  /- 4.6 years and 25 age- and gender-matched control subjects consuming Western diets. Diastolic function was quantified by transmitral flow, Doppler tissue imaging, and model-based image processing ([[MBIP]]) of E waves. C-reactive protein ([[CRP]]), tumor necrosis factor-alpha ([[TNF]]-alpha), and transforming growth factor-beta1 (TGF-beta1) were also measured. No difference in SF was observed between groups; however, standard transmitral Doppler flow DF indexes of the CR group were similar to those of younger individuals, and [[MBIP]]-based, flow-derived DF indexes, reflecting chamber viscoelasticity and stiffness, were significantly lower than in control subjects. Blood pressure, serum [[CRP]], [[TNF]]-alpha, and TGF-beta(1) levels were significantly lower in the CR group (102  /- 10/61  /- 7 mm Hg, 0.3  /- 0.3 mg/l, 0.8  /- 0.5 pg/ml, 29.4  /- 6.9 ng/ml, respectively) compared with the Western diet group (131  /- 11/83  /- 6 mm Hg, 1.9  /- 2.8 mg/l, 1.5  /- 1.0 pg/ml, 35.4  /- 7.1 ng/ml, respectively). Caloric restriction has cardiac-specific effects that ameliorate aging-associated changes in DF. These beneficial effects on cardiac function might be mediated by the effect of CR on blood pressure, systemic inflammation, and myocardial fibrosis.&lt;br /&gt;
|mesh-terms=* Adult&lt;br /&gt;
* Aged&lt;br /&gt;
* Aged, 80 and over&lt;br /&gt;
* Aging&lt;br /&gt;
* C-Reactive Protein&lt;br /&gt;
* Caloric Restriction&lt;br /&gt;
* Cross-Sectional Studies&lt;br /&gt;
* Diastole&lt;br /&gt;
* Echocardiography, Doppler&lt;br /&gt;
* Female&lt;br /&gt;
* Humans&lt;br /&gt;
* Image Processing, Computer-Assisted&lt;br /&gt;
* Male&lt;br /&gt;
* Middle Aged&lt;br /&gt;
* Systole&lt;br /&gt;
* Transforming Growth Factor beta&lt;br /&gt;
* Transforming Growth Factor beta1&lt;br /&gt;
* Tumor Necrosis Factor-alpha&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1016/j.jacc.2005.08.069&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>